The postgraduate course program covers a range of viral infections commonly encountered in critical patients, most particularly in the intensive care units, including viro-sepsis, influenza, COVID-19, Adenovirus, Dengue, Hantavirus, Human Metapneumovirus, Respiratory Syncytial Virus, Human Parainfluenza Viruses, and reactivating agents like Cytomegalovirus, Herpes Simplex Virus, and Epstein-Barr virus.
Intended audience:
Physicians, researchers, and healthcare providers specializing in critical care, infectious diseases, and clinical microbiology.
Objectives:
The course will provide insights into the pathophysiology, immunology, diagnosis, and treatment of these viral infections, as well as discuss pharmacokinetics of antiviral therapy and infection control strategies in the ICU setting.
Course coordinator:
Hakan Erdem, Health Sciences University, Türkiye
Organisers:
ESGCIP – Critically Ill Patients
Kazakh Infectious Diseases Society
Accreditation:
The ESCMID Education team will apply for accreditation to the European Accreditation Council for Continuing Medical Education (EACCME®).
Each participant can only receive the number of credits according to actual participation in the event and upon completion of the feedback survey.
Certification:
Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.
Course Venue:
Al-Farabi Kazakh National University, University Library
71 Al-Farabi Avenue, Almaty, Kazakhstan
Accommodation:
Not included
Registration details:
The registration fee includes coffee breaks and access to the lectures.
The ESCMID Attendance Grant does not cover travel expenses.
Attendance Grant application
Attendance grant application is open until 21.09.2025.